Dergiler / Infectious diseases and clinical microbiology (Online) / 2021 / Cilt: 3 - Sayı: 2

Infectivity of Adult and Pediatric COVID-19Patients

Sayfa
78–86
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The risk of fecal-oral transmission is very low, and strict hand hygiene measures could be preventive.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: We aimed to describe the infectivity of adult and pediatric COVID-19 patients in the presence of viral shedding and anti-SARS-CoV-2 antibody response.Materials and Methods: A total of 408 consequent samples from eleven adults and five pediatric patients with SARS-CoV-2 infection were included.
📊
Temel Bulgular & Veri:Anti-SARS-CoV-2 antibodies were measured.Results: The median duration of RNA shedding in all specimens was 7 (2-15) days in adults and 5 (3-19) days in children.
💡
Sonuç & Katkı:The risk of fecal-oral transmission is very low, and strict hand hygiene measures could be preventive.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: We aimed to describe the infectivity of adult and pediatric COVID-19 patients in the presence of viral shedding and anti-SARS-CoV-2 antibody response.Materials and Methods: A total of 408 consequent samples from eleven adults and five pediatric patients with SARS-CoV-2 infection were included. Reverse transcription-polymerase chain reaction (RT-PCR) and viral culture were performed for the samples obtained every other day from saliva, nasopharynx, feces, serum, urine, and tear. Anti-SARS-CoV-2 antibodies were measured.Results: The median duration of RNA shedding in all specimens was 7 (2-15) days in adults and 5 (3-19) days in children. The median duration from symptom onset to admission was three days. The viral RNA was positive in 44.7 % of the nasopharynx and 37.6% of saliva samples up to 16 days in adults and 19 days in children. We detected the latest viral culture positivity in the nasopharynx on day eight of symptoms. The viral RNA was found in 6.1% of feces, 4.4% of serum, 4.3 % of tear, 2.9% of urine. The earliest seroconversion was the seventh day for adults and the eighth day for children. On the 14th day, total antibody positivity was 78% in adults and 80% in children. After seroconversion, the viral RNA was still detected in the nasopharynx and saliva of three patients; however, the infectious virus was not present.Conclusion: The infectivity of a positive patient is low after eight days of symptoms. The risk of fecal-oral transmission is very low, and strict hand hygiene measures could be preventive.

🔖

Bu Makaleye Atıf Yap

DOĞAN, Ö., ERGÖNÜL, Ö., İNCİR, S., KAPMAZ, M., CAN, F., ÖZER, B., NURTOPU, E., VATANSEVER, C., ÖZCAN, G., OKAN, A., AKTÜRK, H., ÇELİKYURT, A., SAÇKESEN, C., KHALILOVA, F. (2022). Infectivity of Adult and Pediatric COVID-19Patients. Infectious diseases and clinical microbiology (Online), Cilt: 3 - Sayı: 2, 78–86. https://ajindex.com/articles/539065

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. 1 van Kampen JJA, van de Vijver DAMC, Fraaij PLA, Haagmans BL, Lamers MM, OKBA N, et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat Commun. 2021
  2. [CrossRef] 2 Killerby ME, Ata Ur Rasheed M, Tamin A, Harcourt JL, Abedi GR, Lu X, et al. Shedding of culturable virus, seroconversion, and 6-month follow-up antibody responses in the first 14 confirmed cases of COVID-19 in the United States. J Infect Dis. Mar 7, 2021
  3. jiab125. [CrossRef] 3 Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020
  4. 323(18):1843-4. [CrossRef] 4 Wolfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Muller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020
  5. 581(7809):465-9. [CrossRef] 5 Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: Systematic review and meta-analysis. Gastroenterology. Jul, 2020
  6. 159(1):81-95. [CrossRef] 6 Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, Xu H. Positive RT-PCR test results in patients recovered from COVID-19. JAMA. Apr 21, 2020
  7. 323(15):1502-3. [CrossRef] 7 Zheng S, Fan J, Yu F, Feng B, Lou B, Zou Q, et al. Viral load dynamics and disease severity in patients infected with SARSCoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. Apr 21, 2020
  8. m1443. [CrossRef] 8 Liu WD, Chang SY, Wang JT, Tsai MJ, Hung CC, Hsu CL, et al. Prolonged virus shedding even after seroconversion in a patient with COVID-19. J Infect. Aug, 2020
  9. 81(2):318-56. [CrossRef] 9 Bullard J, Dust K, Funk D, Strong JE, Alexander D, Garnett L, et al. Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples. Clin Infect Dis. Dec 17, 2020
  10. 71(10):2663-6. [CrossRef] 10 To KK, Tsang OT, Yip CC, Chan KH, Wu TC, Chan JM, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. Jul 28, 2020
  11. 71(15):841-3. [CrossRef] 11 Sun J, Zhu A, Li H, Zheng K, Zhuang Z, Chen Z, et al. Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Emerg Microbes Infect. Dec, 2020
  12. 9(1):991-3. [CrossRef] 12 Colavita F, Lapa D, Carletti F, Lalle E, Bordi L, Marsella P, et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Int